الفهرس | Only 14 pages are availabe for public view |
Abstract The acute coronary syndromes are the main causes of morbidity and mortality in the industrialized world. These conditions encompass a variety of disease presentations such as unstable angina, non-Q wave myocardial infraction (MI)and transmural (Q wave MI) and thus form a continuous spectrum of syndrome .Vascular endothelial growth factor (VEGF) is a heparinbinding glycoprotein and a potent endothelial cell-specific angiogenic mitogen which is secreted from tumor cells and cells exposed to hypoxia. Therefor, VEGF has been proposed as the most likely candidate in ischemia induced collateral vessel formation, particularly in conditions such as acute coronary syndromes.THE AIM OF THE WORK: was to estimate the serum levels of VEGF in cases of acute coronary syndrome before and after therapy. |